All Type of News
Osong International Bio Exposition 2002 lures many foreign investors in biotechnology field
With the opportunity to open the Bio Expo Korea 2002, which is being held for a month-long period (September 25 through October 24, 2002), a number of foreign investors in the biotechnology field will visit Korea to t...
HIRA to curb NHI payment on Zyprexa
The Health Insurance Review Agency (HIRA) decided to control the NHI payment on Zyprexa, a major tranquilizer (E. Lilly) by classifying it as the 2nd choice of drugs, on the ground that it had no any significant diffe...
Lung cancer on the rise while cardiovascular diseases down.
The death rates in Korea revealed the top with cancer and the diabetic on the sharp rise. The lung cancer rated 25 per 100,000 populations, the top killer of all cancers, then, stomach, liver and cervical cancers show...
Revision of bioequivalence test standards eyed
The Korea Food and Drug Administration has finished drafting a revision of bioequivalence test standards, which includes a provision for allowing pharmaceutical firms to perform the bioequivalence tests by utilizing t...
Sales of 99 pharmaceutical firms total 3.420 trillion won in first half
According to statistics compiled by the Korea Tax Union (KTU), the combined sales of the 99 pharmaceutical firms and the 92 drug wholesalers marked 3.421 trillion won and 1.630 trillion won, respectively, in t...
KPMA backlashes against government's tax incentive reduction.
The KPMA sensitively concerned about the government's tax incentive policy of intending to reduce over the new drug R&D, and earnestly urged them to withdraw its policy.
The KPMA presented a recommendation letter t...
Legal dispute on government's improper cut of insurance drug prices still flared up
In line with the recent administrative suit to suspend the improper reduction of insurance drug prices in a high court following the previous injunction trial at the end of last month, the Ministry of Health and Welfa...
Ex post facto management for KGSP-accredited firms eyed
The Korea Food and Drug Administration (KFDA) announced it will implement its ex post facto management for KGSP-accredited firms next year in accordance with the basic pharmaceutical affairs inspection program, while ...
No pharmacist or oriental pharmacist shall establish more than one pharmacy, health ministry says
The Ministry of Health and Welfare is contemplating the revision of the Korean Pharmaceutical Affairs Law, which is prompted by the recent permission of a corporate pharmacy ruled by the constitutional court.
To t...
2003 health and welfare budget set at 8,378.900 million won
The 2003 budget for the health and welfare was 8.1% up from this year at 8,378,900 million won, which was about 7.5% out of the total national budget of 111,658,300 million won, and it was already submitted to the Na...
